AFYREN is a French Greentech company launched in 2012 to meet the challenge of decarbonizing industrial supplies. Its natural, innovative and proprietary fermentation technology valorizes local biomass from non-food agricultural co-products, replacing petro-sourced ingredients usually used in many product formulations. In 10 years, Afyren managed the scale-up of its technology from laboratory to the first industrial plant. Listed on the Euronext Growth® exchange in Paris since 2021, Afyren is now preparing its international deployment.• Structure the company (from 12 to 120 employees during the scale-up period)• Structure the financing of the company, the first industrial plant & international deployment (150m€+ in equity, grants & debts).• Participate with the CEO to the governance, board members & Investors relationship• Executed the IPO, effective in October 2021, raising a total amount of 70.4 million euros with the objective of accelerating its industrial development. In charge of stock listing management

Investment Director for SPI fund : Minority investment (up to 49%) in companies developing innovative technologies with industrial scale-up projects. SPI fund is operated by Bpifrance. Fund size : 800 M€. Tickets: € 10M to 160M in equityMissions :- Participated the creation of the fund (structuring, doctrine, team recruitment, communication, etc.);- Sourced & executed investments in various sectors (health & industrial Biotech, Additive Manufacturing, Agritech, Eco-mobility, Innovative materials, etc.), with diversified partners (startups to large companies): -> Origination (development of a network with public and private stakeholders), leading due diligence (IP, technical, financial, legal), financial modelling and valuation, negotiation (business, valuation & legal with strong minority rights), legal structuring (shareholder agreement, IP licence, asset and liability guarantees, etc.), project team management, investment monitoring & active role in management of portfolio companies

Evertree - Green Chemistry - created by Avril group, start-up BioPolymer Technologies and SPI fund - develops, manufactures and sales new commercial uses of vegetable proteins. First application targets the wood composite panel industry and helps to reduce or even remove the presence of, and exposure to, formaldehyde.

YposKesi - Red Biotech - created by group AFM-Téléthon and SPI fund - is a french industrial actor dedicated to gene and cell therapies manufacturing, for rare diseases.

Carbiolice - White Biotech - created by start-up Carbios, Limagrain group and SPI fund - develops, manufactures and sales biosourced and biodegradable plastic film compounds, for applications such as mulching films or sampling bags.

Managing investments in Innovative Platforms, into various sectors (Biotech, Intelligent car, Railway, Aquaculture, etc): - Completion of 10 investments on innovative new companies for € 10m (Equity & convertible bonds);- Companies’ portfolio management and support of CDC board members.Implementation and follow-up of SPV investments on real estate industry & complex operations (€ 150m invested/yr representing a global portfolio asset of € 1,2Bn /yr).

Managing a team of 5 people in charge of sales, performance, and market study analysis for the Comex and sales forces. Support of Comex on strategic matters.

Sectors: Industry, HealthCare, Government / International missions (USA, Italy, UK);Examples of missions: Strategic audit, Product portfolio profitability analysis.